• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Surges 100 Points; Manchester United Shares Rise After Q3 Results

    7/10/24 10:16:38 AM ET
    $ICU
    $LGVN
    $MANU
    $SISI
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ICU alert in real time by email

    U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Wednesday.

    The Dow traded up 0.02% to 39,298.72 while the NASDAQ rose 0.53% to 18,526.10. The S&P 500 also rose, gaining, 0.28% to 5,592.62.

    Check This Out: Nvidia, Amazon And 2 Other Stocks Insiders Are Selling

    Leading and Lagging Sectors

    Information technology shares jumped by 0.7% on Wednesday.

    In trading on Wednesday, financials shares fell by 0.3%.

    Top Headline

    Shares of Manchester United plc (NYSE:MANU) gained around 4% on Wednesday after the company reported results for the third quarter.

    The company reported quarterly loss of 31 cents per share which missed the analyst consensus estimate for a loss of 27 cents per share. The company reported quarterly sales of $172.46 million which beat the analyst consensus estimate of $162.92 million.

    Equities Trading UP
                           

    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares shot up 133% to $2.65 after the company announced results for a Swine Model pilot study for Probudur.
    • Shares of Longeveron Inc. (NASDAQ:LGVN) got a boost, surging 79% to $5.14 after the company announced that the FDA granted Regenerative Medicine Advanced Therapy designation to Lomecel-B for the treatment of mild Alzheimer’s Disease.
    • VivoPower International PLC (NASDAQ:VVPR) shares were also up, gaining 58% to $4.0412 after the company announced it secured an extension for a $34 million loan financing facility agreement.

    Equities Trading DOWN

    • Shineco, Inc. (NASDAQ:SISI) shares dropped 41% to $2.66. Shineco's subsidiary Fuzhou Meida signed distribution agreements for water-soluble phospholipid concentrate beverage.
    • Shares of SeaStar Medical Holding Corporation (NASDAQ:ICU) were down 33% to $8.65 after the company entered into a $10 million registered direct offering of 947,868 shares at $10.55 per share.
    • Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) was down, falling 33% to $12.01.

    Also Check This Out: This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

    Commodities

    In commodity news, oil traded down 0.1% to $81.34 while gold traded up 0.9% at $2,388.90.

    Silver traded up 0.9% to $31.34 on Wednesday, while copper rose 1.5% to $4.6445.

    Euro zone

    European shares were higher today. The eurozone's STOXX 600 gained 0.6%, Germany's DAX gained 0.8% and France's CAC 40 rose 0.7%. Spain's IBEX 35 Index rose 1.1%, while London's FTSE 100 rose 0.5%.

    Asia Pacific Markets

    Asian markets closed mostly lower on Wednesday, with Japan's Nikkei gaining 0.61%, Hong Kong's Hang Seng Index declining 0.29%, China's Shanghai Composite Index dipping 0.68% and India's S&P BSE Sensex falling 0.53%.

    Japanese machine tool orders climbed by 9.7% year-over-year to JPY 133,817 million in June compared to a 4.2% rise in the prior month.

    Economics

    • Mortgage applications in the U.S. fell by 0.2% during the first week of July.
    • U.S. wholesale inventories increased by 0.6% month-over-month in May compared to a 0.2% gain in the previous month.

    Now Read This:

    • How To Earn $500 A Month From Citigroup Stock Ahead Of Q2 Earnings Report
    Get the next $ICU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ICU
    $LGVN
    $MANU
    $SISI

    CompanyDatePrice TargetRatingAnalyst
    Manchester United Ltd.
    $MANU
    12/17/2024$23.00Buy
    UBS
    Longeveron Inc.
    $LGVN
    12/6/2024$10.00Buy
    ROTH MKM
    Manchester United Ltd.
    $MANU
    12/9/2022Buy → Hold
    Deutsche Bank
    Manchester United Ltd.
    $MANU
    3/21/2022$18.00Hold → Buy
    Deutsche Bank
    Longeveron Inc.
    $LGVN
    1/5/2022$20.00Buy
    EF Hutton
    More analyst ratings

    $ICU
    $LGVN
    $MANU
    $SISI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Van Heel Kenneth was granted 3,000 shares, increasing direct ownership by 61% to 7,940 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    2/10/26 4:58:51 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Director Neuman John was granted 3,000 shares, increasing direct ownership by 33% to 12,200 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    2/10/26 4:58:22 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Director Baird Jennifer A was granted 3,000 shares, increasing direct ownership by 83% to 6,620 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    2/10/26 4:57:09 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    $ICU
    $LGVN
    $MANU
    $SISI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th

    DENVER, March 09, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today that Eric Schlorff, CEO of SeaStar Medical, will participate in a fireside CEO chat with David Bautz, Senior Biotech Analyst at Zacks Small-Cap Research, at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on March 11, 2026. DATE: March 11th TIME: 12:00 pm E.T. REGISTER HERE Available for 1x1 meetings: March 11. Schedule 1x1 Meetings here. The event will be conducted as a live, interactive online forum, offe

    3/9/26 8:35:00 AM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

    DENVER, March 05, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company, announced today that it has completed the required enrollment in the SAVE Registry, a Post-Approval Study (PAS) required by the FDA that is designed to confirm the safety of the QUELIMMUNE™ therapy as a treatment for children with acute kidney injury (AKI) due to sepsis or a septic condition requiring renal replacement therapy (RRT). The registry has successfully enrolled 50 patients, and the company will be reporting the 28-day safety results from the SAVE Registry to the FDA upon completion of its analysis of the data. "The early results from the SAVE Regis

    3/5/26 8:20:00 AM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them

    Issued on behalf of Avaí Bio, Inc.VANCOUVER, BC, March 3, 2026 /CNW/ -- USANewsGroup.com News Commentary -- The global cell therapy market is projected to surpass $8.2 billion in 2026, driven by a wave of clinical breakthroughs and manufacturing milestones reshaping regenerative medicine[1]. CAR T-cell therapy alone is valued at nearly $7 billion this year, expanding at an 18% compound annual growth rate as off-the-shelf platforms eliminate the logistical barriers that once limited patient access[2]. Among the companies advancing next-generation cell-based treatments are Avaí Bio (OTCQB:AVAI), FibroBiologics (NASDAQ:FBLG), Fate Therapeutics (NASDAQ:FATE), Mesoblast (NASDAQ:MESO), and Longeve

    3/3/26 10:02:00 AM ET
    $FATE
    $FBLG
    $LGVN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ICU
    $LGVN
    $MANU
    $SISI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS initiated coverage on Manchester United with a new price target

    UBS initiated coverage of Manchester United with a rating of Buy and set a new price target of $23.00

    12/17/24 8:31:08 AM ET
    $MANU
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    ROTH MKM initiated coverage on Longeveron with a new price target

    ROTH MKM initiated coverage of Longeveron with a rating of Buy and set a new price target of $10.00

    12/6/24 7:54:21 AM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Manchester United downgraded by Deutsche Bank

    Deutsche Bank downgraded Manchester United from Buy to Hold

    12/9/22 1:57:54 PM ET
    $MANU
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ICU
    $LGVN
    $MANU
    $SISI
    SEC Filings

    View All

    SEC Form PRE 14A filed by Longeveron Inc.

    PRE 14A - Longeveron Inc. (0001721484) (Filer)

    3/3/26 7:59:59 AM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Manchester United Ltd.

    6-K - Manchester United plc (0001549107) (Filer)

    2/26/26 4:06:25 PM ET
    $MANU
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form 6-K filed by Manchester United Ltd.

    6-K - Manchester United plc (0001549107) (Filer)

    2/25/26 7:00:14 AM ET
    $MANU
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ICU
    $LGVN
    $MANU
    $SISI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Baird Jennifer A bought $987 worth of shares (4,200 units at $0.24), increasing direct ownership by 13% to 36,200 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    12/22/25 6:55:38 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Messinger Michael bought $5,098 worth of shares (14,500 units at $0.35), increasing direct ownership by 483% to 17,500 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    12/11/25 6:49:59 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Director Van Heel Kenneth bought $30,812 worth of shares (35,000 units at $0.88), increasing direct ownership by 243% to 49,400 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    8/28/25 5:28:58 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    $ICU
    $LGVN
    $MANU
    $SISI
    Leadership Updates

    Live Leadership Updates

    View All

    Longeveron® Appoints Stephen H. Willard as Chief Executive Officer

    Mr. Willard has a 30+ year track record of leadership across public and private sectors as CEO of multiple biotechnology and pharmaceutical firms, with an impressive history of delivering significant fundraises and strategic collaborationsCorporate focus on delivering top-line results from the pivotal Phase 2b clinical trial in Hypoplastic Left Heart Syndrome (HLHS), anticipated in the third quarter of 2026 Than Powell stepped down as interim CEO; will remain with the Company to support the leadership transition and continue his work in the Company's on-going business development activities MIAMI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage regenerati

    2/13/26 4:30:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VivoPower to Open Dublin Office, Appoints Shane Whelan to Global Advisory Council to Leverage Hyperscaler Relationships and Build Sovereign AI Data Center Business

    Based in Dublin, Mr. Whelan is one of Europe's leading real estate and infrastructure asset developers  He has multi-decade relationships with hyperscalers, including Google, Microsoft, and Amazon Development portfolio exceeds $2 billion in gross development value, spanning 3.5 million square feet Mr. Whelan will establish a Dublin office for VivoPower as it scales up its Sovereign AI data center infrastructure business, further advancing its Power -to-X strategy LONDON, UK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR) ("VivoPower" or the "Company"), is pleased to announce the appointment of Shane Whelan to its Global Advisory Council. Mr. Whelan is a hi

    1/14/26 8:00:00 AM ET
    $VVPR
    Power Generation
    Utilities

    VivoPower Appoints Rachel Pether, Sovereign Wealth Fund Expert, to Global Advisory Council

    Appointment further strengthens VivoPower's footprint across the Middle East, a priority growth region for the Company's Sovereign AI digital infrastructure and electric mobility platforms Based in the UAE for almost 18 years, Ms. Pether is highly reputed in both the DeFi and TradFi sectors Ms. Pether is the Head of Middle East at 3iQ, one of the world's largest digital asset managers, and a Senior Advisor to the Sovereign Wealth Fund Institute (SWFI); she was previously in a leadership position at Mubadala, one of the world's largest sovereign wealth funds LONDON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ:VVPR) ("VivoPower" or the "Company"), a leading B Cor

    1/8/26 8:32:00 AM ET
    $VVPR
    Power Generation
    Utilities

    $ICU
    $LGVN
    $MANU
    $SISI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by SeaStar Medical Holding Corporation

    SC 13G - SeaStar Medical Holding Corp (0001831868) (Subject)

    11/14/24 5:35:52 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Longeveron Inc.

    SC 13G/A - Longeveron Inc. (0001721484) (Subject)

    11/14/24 4:20:18 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Manchester United Ltd.

    SC 13G/A - Manchester United plc (0001549107) (Subject)

    11/14/24 4:14:22 PM ET
    $MANU
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ICU
    $LGVN
    $MANU
    $SISI
    Financials

    Live finance-specific insights

    View All

    SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

    Business highlights include: Three new top-rated children's hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury (AKI)Commercial use of QUELIMMUNE therapy demonstrates positive survival results as reported from the QUELIMMUNE SAVE Surveillance RegistryNew clinical sites added to expand adult NEUTRALIZE-AKI pivotal trial enrollmentStrengthened the balance sheet, raising $12.4 million to fund future operationsWebcast call today at 4:30 p.m. Eastern Time DENVER, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure

    11/13/25 4:05:00 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

    DENVER, Nov. 05, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its third quarter financial results after market close on Thursday, November 13, 2025, and host a webcast and conference call to discuss its financial results and business progress. Date/Time:Thursday, November 13, 2025, at 4:30 p.m. ET / 2:30 p.m. MTWebcast:The live webcast and replay can be found here.Dial-in number:To join the conference call via phone, please pre-register online here to receive a telephone number

    11/5/25 10:03:00 AM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025

    MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced that it will report third quarter 2025 financial results and provide a business update on Tuesday, November 4, 2025 after the U.S. financial markets close. The Company will host a conference call and webcast the same day at 4:30 p.m. ET. Conference Call and Webcast Details:   Conference Call Number: 1.877.407.0789Conference ID: 13755997   Call me™ Feature: Click HereWebcast: Click Here An archived replay of the webcast will be available on the "Events & Presenta

    10/28/25 9:15:00 AM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care